Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Colchicine for the treatment of COVID-19
Agata Mikołajewska, Anna-Lena Fischer, Vanessa Piechotta, et al.
Cochrane library (2021) Vol. 2021, Iss. 10
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Ivermectin for preventing and treating COVID-19
Maria Popp, Stefanie Reis, Selina Schießer, et al.
Cochrane library (2022) Vol. 2024, Iss. 3
Open Access | Times Cited: 154
Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19
Xue Li, Ziqi Zhang, Zhenling Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 49
Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence
Carina Wagner, Mirko Griesel, Agata Mikołajewska, et al.
Cochrane library (2022) Vol. 2022, Iss. 11
Open Access | Times Cited: 47
Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation
Aldo Bonaventura, Alessandra Vecchiè, Lorenzo Dagna, et al.
Inflammation Research (2022) Vol. 71, Iss. 3, pp. 293-307
Open Access | Times Cited: 42
Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions
Yujie Jiang, Tingmei Zhao, Xueyan Zhou, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 42
Post-covid-19 conditions in adults: systematic review and meta-analysis of health outcomes in controlled studies
Juan Víctor Ariel Franco, Luis Garegnani, Maria‐Inti Metzendorf, et al.
BMJ Medicine (2024) Vol. 3, Iss. 1, pp. e000723-e000723
Open Access | Times Cited: 13
High Doses of Colchicine Act As “Silver Bullets” Against Severe COVID-19
Alexander Lilov, Kiril Palaveev, Vanio Mitev
Cureus (2024)
Open Access | Times Cited: 9
Long-Term Health Symptoms and Sequelae Following SARS-CoV-2 Infection: An Evidence Map
Juan Víctor Ariel Franco, Luis Garegnani, Gisela Oltra, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 16, pp. 9915-9915
Open Access | Times Cited: 35
Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults
S Kiene, Melanie Albrecht, Sebastian Theurich, et al.
Cochrane library (2024) Vol. 2024, Iss. 11
Closed Access | Times Cited: 6
Transcriptional regulation of SARS-CoV-2 receptor ACE2 by SP1
Hui Han, Rong‐Hua Luo, Xin‐Yan Long, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 5
Synthesis of Seleno-Dibenzocycloheptenones/Spiro[5.5]Trienones by Radical Cyclization of Biaryl Ynones
Helen A. Goulart, Ricardo H. Bartz, Thiago J. Peglow, et al.
The Journal of Organic Chemistry (2022) Vol. 87, Iss. 6, pp. 4273-4283
Closed Access | Times Cited: 26
Comparison of treatment of COVID-19 with inhaled bromhexine, higher doses of colchicine and hymecromone with WHO-recommended paxlovid, molnupiravir, remdesivir, anti-IL-6 receptor antibodies and baricitinib
Vanio Mitev
Pharmacia (2023) Vol. 70, Iss. 4, pp. 1177-1193
Open Access | Times Cited: 13
Investigating the Nexus of NLRP3 Inflammasomes and COVID-19 Pathogenesis: Unraveling Molecular Triggers and Therapeutic Strategies
Qun He, Da Hu, Fuqiang Zheng, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 213-213
Open Access | Times Cited: 4
From standard systematic reviews to living systematic reviews
Claudia Breuer, Jörg J. Meerpohl, Waldemar Siemens
Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen (2023) Vol. 176, pp. 76-81
Open Access | Times Cited: 11
Colchicine—The Divine Medicine against COVID-19
Vanio Mitev
Journal of Personalized Medicine (2024) Vol. 14, Iss. 7, pp. 756-756
Open Access | Times Cited: 3
Recommendations on the in-hospital treatment of patients with COVID-19
Stefan Kluge, Jakob J Malin, Falk Fichtner, et al.
Deutsches Ärzteblatt international (2021)
Open Access | Times Cited: 25
What is the lowest lethal dose of colchicine?
Vanio Mitev
Biotechnology & Biotechnological Equipment (2023) Vol. 37, Iss. 1
Open Access | Times Cited: 9
Neutrophil Extracellular Traps, Sepsis and COVID-19 – A Tripod Stand
Esmeiry Ventura-Santana, Joshua R. Ninan, Caitlin M. Snyder, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Evidence-based practices in sustainable travel behavior intervention: A knowledge graph-based systematic review
Jian Li, Chenjie Xu
Journal of Traffic and Transportation Engineering (English Edition) (2024) Vol. 11, Iss. 2, pp. 293-311
Open Access | Times Cited: 2
Colchicine—The Divine Medicine against COVID-19
Vanio Mitev
(2024)
Open Access | Times Cited: 2
Clinical update on COVID-19 for the emergency and critical care clinician: Medical management
Brit Long, Summer Chavez, Brandon M Carius, et al.
The American Journal of Emergency Medicine (2022) Vol. 56, pp. 158-170
Open Access | Times Cited: 13
Treatment with COLchicine in hospitalized patients affected by COVID-19: The COLVID-19 trial
Carlo Perricone, Mirko Scarsi, Antonio Brucato, et al.
European Journal of Internal Medicine (2022) Vol. 107, pp. 30-36
Open Access | Times Cited: 12
Methodological quality and reporting quality of COVID-19 living systematic review: a cross-sectional study
Jiefeng Luo, Zhe Chen, Dan Liu, et al.
BMC Medical Research Methodology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Interferon-I Modulation and Natural Products: Unraveling Mechanisms and Therapeutic Potential in Severe COVID-19
Yuheng Song, Jiani Lu, Pengcheng Qin, et al.
Cytokine & Growth Factor Reviews (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top